Adalimumab and Infliximab Impair SARS-CoV-2 Antibody Responses: Results from a Therapeutic Drug Monitoring Study in 11 422 Biologic-Treated Patients
阿达木单抗和英夫利昔单抗会削弱SARS-CoV-2抗体反应:一项纳入11422名接受生物制剂治疗患者的治疗药物监测研究结果
期刊:Journal of Crohns & Colitis
影响因子:8.7
doi:10.1093/ecco-jcc/jjab153
Chanchlani, Neil; Lin, Simeng; Chee, Desmond; Hamilton, Benjamin; Nice, Rachel; Arkir, Zehra; Bewshea, Claire; Cipriano, Bessie; Derikx, Lauranne A A P; Dunlop, Allan; Greathead, Louise; Griffiths, Rachel L; Ibraheim, Hajir; Kelleher, Peter; Kok, Klaartje B; Lees, Charlie W; MacDonald, Jonathan; Sebastian, Shaji; Smith, Philip J; McDonald, Timothy J; Irving, Peter M; Powell, Nick; Kennedy, Nicholas A; Goodhand, James R; Ahmad, Tariq